Evaluation of the Efficacy of Probiotics Domiciliary Protocols for the Management of Periodontal Disease, in Adjunction of Non-Surgical Periodontal Therapy (NSPT): A Systematic Literature Review
Source abstract
Abstract
Introduction: Periodontitis is a multifactorial chronic inflammatory disease induced by a dysbiosis between the host and oral microbiota, which can compromise the host’s immune defenses and lead to the destruction of periodontal tissues. Despite the efficacy of non-surgical periodontal therapy (NSPT) as the gold standard of periodontal treatment, its application can produce lower results due to anatomical and microbiological limitations. This systematic literature review was performed to assess the long-term efficacy of the effects of probiotics as an adjunct to NSPT compared to the control groups with follow-up of clinical, microbiological and immunological outcomes. Materials and methods: A literature review was conducted, considering manuscripts published from November 2016 to February 2022. The research question was formulated following the population, intervention, comparison and outcome strategies. Randomized controlled trials (RCT), systematic review and meta-analysis investigating the periodontal efficacy of domiciliary probiotic therapy in an adjunct to the mechanical therapy were included. Results: Regarding clinical outcomes, there is a reduction in periodontal probing depth (PPD), clinical attachments level (CAL), bleeding on probing (BoP) and plaque index (PI) for the test groups compared to the control groups in a short-term period. No differences were generally observed in the following indices over a period of more than 3 months for most studies considered. Conclusions: Weak evidence suggests that the use of probiotics as an adjunct to non-surgical periodontal therapy treatment may be able to show improvements in periodontal clinical parameters for up to 3 months. However, a significant and large heterogeneity of studies, along with the absence of long-term microbiological and immunological data, preclude any definitive conclusions.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Oral microbiology and periodontitis research · Dental Health and Care Utilization · HIV/AIDS oral health manifestations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Unit of Dental Hygiene, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy
Department of Stomatology, Tuscan Stomatologic Institute, Foundation for Dental Clinic, Research and Continuing Education, 55041 Camaiore, Italy
Unit of Orthodontics and Paediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, Italy
References (36)
Show source-provided references
1. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement10.1016/j.chom.2011.10.006 ↗
2. Global burden of oral diseases: Emerging concepts, management and interplay with systemic health10.1111/odi.12428 ↗
3. Comparison of Red-Complex Bacteria Between Saliva and Subgingival Plaque of Periodontitis Patients: A Systematic Review and Meta-Analysis10.3389/fcimb.2021.727732 ↗
4. Immuno-pathogenesis of periodontal disease: Current and emerging paradigms10.1007/s40496-014-0017-8 ↗
5. Beyond the red complex and into more complexity: The polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology10.1111/j.2041-1014.2012.00663.x ↗
6. The inflammophilic character of the periodontitis-associated microbiota10.1111/omi.12065 ↗
7. Nonsurgical periodontal treatment
8. Clinical significance of non-surgical periodontal therapy: An evidence-based perspective of scaling and root planing10.1034/j.1600-051X.29.s2.4.x ↗
9. A systematic review on the clinical efficacy of subgingival debridementinthetreatment of chronic periodontitis10.1034/j.1600-051X.29.s3.3.x ↗
10. Butera, A., Gallo, S., Maiorani, C., Molino, D., Chiesa, A., Preda, C., Esposito, F., and Scribante, A. (2021). Probiotic Alternative to Chlorhexidine in Periodontal Therapy: Evaluation of Clinical and Microbiological Parameters. Microorganisms, 9.10.3390/microorganisms9010069 ↗
11. Scribante, A., Gallo, S., Pascadopoli, M., Soleo, R., Di Fonso, F., Politi, L., Venugopal, A., Marya, A., and Butera, A. (2022). Management of Periodontal Disease with Adjunctive Therapy with Ozone and Photobiomodulation (PBM): A Randomized Clinical Trial. Photonics, 9.10.3390/photonics9030138 ↗
12. The effect of periodontal therapy on the composition of the subgingival microbiota10.1111/j.1600-0757.2006.00191.x ↗
13. Food and Agriculture Organization of the United Nations/World Health Organization (2022, September 15). Guidelines for the Evaluation of Probiotics in Food. Available online: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
14. Use of probiotics and oral health10.1007/s40496-017-0159-6 ↗
15. Subgingival Microbial Profile and Production of Proinflammatory Cytokines In Chronic Periodontitis10.2478/folmed-2014-0022 ↗
16. Antifungal effect of antimicrobial peptides (AMPs LR14) derived from Lactobacillus plantarum strain LR/14 and their applications in prevention of grain spoilage10.1016/j.fm.2014.02.005 ↗
17. The dual role of bacteriocins as anti- and probiotics10.1007/s00253-008-1726-5 ↗
18. Probiotics and gastrointestinal conditions: An overview of evidence from the Cochrane Collaboration10.1016/j.nut.2017.06.024 ↗
19. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features10.1016/j.cell.2018.08.041 ↗
20. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.10.1371/journal.pmed.1000097 ↗
21. Higgins, J.P.T., Green, S., and Assessing risk of Bias in Included Studies (2019, June 11). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. Available online: http://handbook-5-1.cochrane.org/chapter_8/8_assessing_risk_of_bias_in_included_studies.htm.
22. Invernici, M.M., Furlaneto, F.A., Salvador, S.L., Ouwehand, A.C., Salminen, S., Mantziari, A., Vinderola, G., Ervolino, E., Santana, S.I., and Messora, M.R. (2020). Bifidobac- terium animalis subsp lactis HN019 presents antimicrobial po- tential against periodontopathogens and modulates the immunological response of oral mucosa in periodontitis patients. PLoS ONE, 15.10.1371/journal.pone.0238425 ↗
23. Effects of Bi- fidobacterium probiotic on the treatment of chronic pe- riodontitis: A randomized clinical trial10.1111/jcpe.12995 ↗
24. Clincal Efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study10.1007/s00784-019-03065-x ↗
25. Effects of adjunctive light-activated disinfection and probiotics on clinical and microbiological parameters in periodontal treatment: A randomized, controlled, clinical pilot study10.1007/s00784-020-03727-1 ↗
26. Probiotic strains of Lactobacillus brevis and Lactobacillus plan- tarum as adjunct to non-surgical periodontal therapy: 3-month results of a randomized controlled clinical trial10.1007/s00784-020-03449-4 ↗
27. Effects of adjunctive probiotic L. reuteri lozenges on S/RSD outcomes at molar sites with deep pockets10.1111/jcpe.13329 ↗
28. A dual-strain Lactobacilli reuteri probiotic improves the treatment of residual pockets: A randomized controlled clinical trial10.1111/jcpe.13198 ↗
29. Effects of Lactobacillus reuteri as an adjunct to the treatment of periodontitis in smokers: Randomised clinical trial10.3920/BM2018.0150 ↗
30. Microbiological and clin- ical effects of probiotics and antibiotics on nonsurgical treat- ment of chronic periodontitis: A randomized placebocon- trolled trial with 9-month follow-up10.1590/1678-7757-2017-0075 ↗
31. Effectiveness of scaling and root planing with and with- out adjunct probiotic therapy in the treatment of chronic peri- odontitis among shamma users and non-users: A randomized controlled trial10.1002/JPER.19-0464 ↗
32. Butera, A., Gallo, S., Pascadopoli, M., Maiorani, C., Milone, A., Alovisi, M., and Scribante, A. (2022). Paraprobiotics in Non-Surgical Periodontal Therapy: Clinical and Microbiological Aspects in a 6-Month Follow-Up Domiciliary Protocol for Oral Hygiene. Microorganisms, 10.10.3390/microorganisms10020337 ↗
33. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri
34. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic peri- odontitis: A 1-year follow-up study10.1111/jcpe.12387 ↗
35. Effect of the probioticLactobacilli reuteri(Prodentis) in the management of periodontal disease: A preliminary randomized clinical trial10.3402/jom.v2i0.5344 ↗
36. A CBCT based analysis of the correlation between volumetric morphology of the frontal sinuses and the facial growth pattern in caucasian subjects10.1186/s13005-022-00308-3 ↗